# Joyce O’Shaughnessy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/joyce-o-shaughnessy-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,889 |
| Field | Advanced Breast Cancer Therapies |
| h-index | 69 |
| i10-index | 214 |
| Last Known Institution | Baylor University Medical Center |
| OpenAlex ID | https://openalex.org/A5071432873 |
| ORCID iD | https://orcid.org/0000-0001-6764-2807 |
| Works | 664 |

## Researcher papers

- [Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study](https://scholariq.org/papers/adjuvant-abemaciclib-combined-with-endocrine-therapy-for-high-risk-early-breast/)
- [Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer](https://scholariq.org/papers/biomarker-analyses-in-the-phase-iii-ascent-study-of-sacituzumab-govitecan-versus/)
- [Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities](https://scholariq.org/papers/genome-and-transcriptome-sequencing-in-prospective-metastatic-triple-negative/)
- [Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials](https://scholariq.org/papers/anthracycline-containing-and-taxane-containing-chemotherapy-for-early-stage/)
- [Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer](https://scholariq.org/papers/clinical-and-biomarker-findings-of-neoadjuvant-pembrolizumab-and-carboplatin/)

## Researcher topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)

## Researcher university

- [Baylor University Medical Center](https://scholariq.org/institutions/baylor-university-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.